Pratik Shah
CIK 1580787 · President, CEO and Chairperson · last filed 2026-06-26
Pratik Shah is a President, CEO and Chairperson who has filed 20 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SPRY, was dated Jun 26, 2026. Across all open-market trades the lifetime net is +$600.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $19.1M across reported positions. 4 SEC filings were submitted jointly with Pratik Shah Living Trust dated June 15, 2011.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
DSGN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD, CA 92011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPRY | Director | 4,474,554 | $3.92 | $17.54M | $0 | 7 | 2026-06-26 |
| DSGN | President, CEO and Chairperson | 154,923 | $10.34 | $1.60M | $500.0K | 7 | 2026-01-05 |
| THOR | Director | 0 | $25.39 | $0 | $0 | 2 | 2020-01-24 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | President and CEO | 0 | — | — | $100.0K | 3 | 2015-05-06 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2026-01-05 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2025-12-11 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2025-11-14 | SPRY | Gift (G) | −350,000 | $0 | EDGAR |
| 2025-06-27 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | DSGN | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | SPRY | Grant (A) | — | $0 | EDGAR |
| 2024-06-17 | SPRY | Gift (G) | −1,332,900 | $0 | EDGAR |
| 2024-06-07 | SPRY | Gift (G) | −1,332,950 | $0 | EDGAR |
| 2023-09-05 | DSGN | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.